MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
致病原虫的医学结构基因组学
基本信息
- 批准号:8362112
- 负责人:
- 金额:$ 0.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-01 至 2012-02-29
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAfrican TrypanosomiasisBindingChagas DiseaseChemicalsFundingGrantL-SelenomethionineLeishmaniaLeishmaniasisMedicalNational Center for Research ResourcesPhasePlasmodiumPrincipal InvestigatorProteinsProtozoaRadiationResearchResearch InfrastructureResourcesRoboticsScreening procedureSourceStructureTrypanosomaTrypanosoma cruziUnited States National Institutes of Healthcostfollow-uppathogensmall moleculestructural biologystructural genomics
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
This proposal encompasses the initial structure determination of medically relevant target proteins from the eukaryotic pathogens Trypanosoma bruci (African sleeping sickness). T. cruzi (Chagas disease), Leishmania spp. (leishmaniasis) and Plasmodium spp. (maleria), and follow-up screening of small molecule cocktails to identify chemical fragments that bind at the active site. Initial structure determinations will rely primarily on SeMet MAD/SAD phasing. Screening of cocktail soaks can be done at fixed wavelength, but benifits greatly from the use of robotic automounting and screening.
这个子项目是利用这些资源的众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ETHAN A MERRITT其他文献
ETHAN A MERRITT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ETHAN A MERRITT', 18)}}的其他基金
Drug Design Targeting ProRS in Anaerobic Parasites
针对厌氧寄生虫中 ProRS 的药物设计
- 批准号:
9091419 - 财政年份:2015
- 资助金额:
$ 0.22万 - 项目类别:
MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
致病原虫的医学结构基因组学
- 批准号:
8362415 - 财政年份:2011
- 资助金额:
$ 0.22万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
7937610 - 财政年份:2010
- 资助金额:
$ 0.22万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
8097594 - 财政年份:2010
- 资助金额:
$ 0.22万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
8288293 - 财政年份:2010
- 资助金额:
$ 0.22万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
8688133 - 财政年份:2010
- 资助金额:
$ 0.22万 - 项目类别:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
钙依赖性蛋白激酶 1 作为弓形虫和微小弯曲菌的药物靶点
- 批准号:
8485534 - 财政年份:2010
- 资助金额:
$ 0.22万 - 项目类别:
MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
致病原虫的医学结构基因组学
- 批准号:
8170019 - 财政年份:2010
- 资助金额:
$ 0.22万 - 项目类别:
Prediction of Protein Crystallization and Diffraction Quality
蛋白质结晶和衍射质量的预测
- 批准号:
7707893 - 财政年份:2009
- 资助金额:
$ 0.22万 - 项目类别:
相似海外基金
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10511408 - 财政年份:2022
- 资助金额:
$ 0.22万 - 项目类别:
A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
调查马拉维野生动物中东非锥虫病生态学的“同一个健康”方法
- 批准号:
476178 - 财政年份:2022
- 资助金额:
$ 0.22万 - 项目类别:
Studentship Programs
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10677879 - 财政年份:2022
- 资助金额:
$ 0.22万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10466942 - 财政年份:2021
- 资助金额:
$ 0.22万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10296873 - 财政年份:2021
- 资助金额:
$ 0.22万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10706306 - 财政年份:2021
- 资助金额:
$ 0.22万 - 项目类别:
Reducing and replacing the animal cost of functional genetics in African trypanosomiasis
减少和替代非洲锥虫病功能遗传学的动物成本
- 批准号:
NC/W001144/1 - 财政年份:2021
- 资助金额:
$ 0.22万 - 项目类别:
Research Grant
Development of new drug for African trypanosomiasis based on elucidation of the mechanism of antiprotozoal action by ribavirin.
基于利巴韦林抗原虫作用机制的阐明,开发治疗非洲锥虫病的新药。
- 批准号:
21K18230 - 财政年份:2021
- 资助金额:
$ 0.22万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Development of a novel control measure for African trypanosomiasis based on the blocking of lifecycle progression
基于生命周期进展阻断的非洲锥虫病新型控制措施的开发
- 批准号:
20K07467 - 财政年份:2020
- 资助金额:
$ 0.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Drug-diagnostic co-development in Tropical Medicine, combating Human African Trypanosomiasis
热带医学药物诊断联合开发,抗击非洲人类锥虫病
- 批准号:
18KK0454 - 财政年份:2019
- 资助金额:
$ 0.22万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))














{{item.name}}会员




